These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22921246)

  • 1. Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent.
    Sinisi M; Intini FP; Natile G
    Inorg Chem; 2012 Sep; 51(18):9694-704. PubMed ID: 22921246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.
    Huo S; Shen S; Liu D; Shi T
    J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid.
    Dabbish E; Ponte F; Russo N; Sicilia E
    Inorg Chem; 2019 Mar; 58(6):3851-3860. PubMed ID: 30843385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computational mechanistic investigation into the reduction of Pt(iv) prodrugs with two axial chlorides by biological reductants.
    Ejehi Z; Ariafard A
    Chem Commun (Camb); 2017 Jan; 53(8):1413-1416. PubMed ID: 28079213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.
    Chen CK; Zhang JZ; Aitken JB; Hambley TW
    J Med Chem; 2013 Nov; 56(21):8757-64. PubMed ID: 24107138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.
    Lemma K; Shi T; Elding LI
    Inorg Chem; 2000 Apr; 39(8):1728-34. PubMed ID: 12526561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design.
    Zhang JZ; Bonnitcha P; Wexselblatt E; Klein AV; Najajreh Y; Gibson D; Hambley TW
    Chemistry; 2013 Jan; 19(5):1672-6. PubMed ID: 23255183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pt(IV) complexes as prodrugs for cisplatin.
    Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
    J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thioethers on DNA platination by trans-platinum complexes.
    Li C; Huang R; Ding Y; Sletten E; Arnesano F; Losacco M; Natile G; Liu Y
    Inorg Chem; 2011 Sep; 50(17):8168-76. PubMed ID: 21812429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions.
    Wexselblatt E; Yavin E; Gibson D
    Angew Chem Int Ed Engl; 2013 Jun; 52(23):6059-62. PubMed ID: 23686723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of oxidative DNA damage and DNA-crosslink formation induced by cis-diammine-tetrachloro-platinum(IV) in the presence of endogenous reductants.
    Nakai T; Ando M; Okamoto Y; Ueda K; Kojima N
    J Inorg Biochem; 2011 Jan; 105(1):1-5. PubMed ID: 21134595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.
    Cubo L; Hambley TW; Sanz Miguel PJ; Carnero A; Navarro-Ranninger C; Quiroga AG
    Dalton Trans; 2011 Jan; 40(2):344-7. PubMed ID: 20936210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs.
    Nemirovski A; Vinograd I; Takrouri K; Mijovilovich A; Rompel A; Gibson D
    Chem Commun (Camb); 2010 Mar; 46(11):1842-4. PubMed ID: 20198227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate.
    Zhang JZ; Wexselblatt E; Hambley TW; Gibson D
    Chem Commun (Camb); 2012 Jan; 48(6):847-9. PubMed ID: 22124352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.
    Guido E; D'Amico G; Russo N; Sicilia E; Rizzato S; Albinati A; Romeo A; Plutino MR; Romeo R
    Inorg Chem; 2011 Mar; 50(6):2224-39. PubMed ID: 21341750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs.
    Medrano MÁ; Álvarez-Valdés A; Perles J; Lloret-Fillol J; Muñoz-Galván S; Carnero A; Navarro-Ranninger C; Quiroga AG
    Chem Commun (Camb); 2013 May; 49(42):4806-8. PubMed ID: 23591566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
    J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)].
    Margiotta N; Ranaldo R; Intini FP; Natile G
    Dalton Trans; 2011 Dec; 40(48):12877-85. PubMed ID: 22064914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
    Westendorf AF; Bodtke A; Bednarski PJ
    Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.